As we expect our clinical and pre-clinical programs and pipeline to continue to grow, we look forward to utilizing Genedata Profiler and Genedata Managed IT Services to assist us in our mission to develop safe, targeted, effective therapeutics for cancer patients.
Working closely with Genedata, we have generated a digital biomarker research platform that will enable Merck scientists to better utilize clinical and translational data to generate innovative ideas for new biomarkers and drug targets.
Joern Peter Halle Head of Immuno-oncology and External Innovation
We chose Genedata Profiler because it is the end-to-end enterprise software able to harmonize our dispersed data analysis pipelines, enhancing our capacity to analyze large amounts of high-dimensional ‘omics data emerging from our rapidly growing number of translational and clinical research projects.
Kimio Terao Department Manager of Clinical Pharmacology